Literature DB >> 28904126

NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during Toxoplasma gondii Infection.

Lanny Gov1, Christine A Schneider1, Tatiane S Lima1, William Pandori1, Melissa B Lodoen2.   

Abstract

IL-1β is produced by myeloid cells and acts as a critical mediator of host defense during infection and injury. We found that the intracellular protozoan parasite Toxoplasma gondii induced an early IL-1β response (within 4 h) in primary human peripheral blood monocytes isolated from healthy donors. This process involved upregulation of IL-1β, IL-1RN (IL-1R antagonist), and NLRP3 transcripts, de novo protein synthesis, and the release of pro- and mature IL-1β from infected primary monocytes. The released pro-IL-1β was cleavable to mature bioactive IL-1β in the extracellular space by the protease caspase-1. Treatment of primary monocytes with the NLRP3 inhibitor MCC950 or with extracellular potassium significantly reduced IL-1β cleavage and release in response to T. gondii infection, without affecting the release of TNF-α, and indicated a role for the inflammasome sensor NLRP3 and for potassium efflux in T. gondii-induced IL-1β production. Interestingly, T. gondii infection did not induce an IL-1β response in primary human macrophages derived from the same blood donors as the monocytes. Consistent with this finding, NLRP3 was downregulated during the differentiation of monocytes to macrophages and was not induced in macrophages during T. gondii infection. To our knowledge, these findings are the first to identify NLRP3 as an inflammasome sensor for T. gondii in primary human peripheral blood cells and to define an upstream regulator of its activation through the release of intracellular potassium.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28904126      PMCID: PMC5648586          DOI: 10.4049/jimmunol.1700245

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Reduced expression of IL-6 and IL-1alpha mRNAs in secretory phase endometrium of women with recurrent miscarriage.

Authors:  Melinda J Jasper; Kelton P Tremellen; Sarah A Robertson
Journal:  J Reprod Immunol       Date:  2006-10-10       Impact factor: 4.054

2.  NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.

Authors:  William H Witola; Ernest Mui; Aubrey Hargrave; Susan Liu; Magali Hypolite; Alexandre Montpetit; Pierre Cavailles; Cordelia Bisanz; Marie-France Cesbron-Delauw; Gilbert J Fournié; Rima McLeod
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  Role of TNF and IL-1 in infections with Toxoplasma gondii.

Authors:  H R Chang; G E Grau; J C Pechère
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

5.  The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion.

Authors:  Kevin W Tosh; Lara Mittereder; Sandra Bonne-Annee; Sara Hieny; Thomas B Nutman; Steven M Singer; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2015-11-23       Impact factor: 5.422

6.  Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii.

Authors:  Gezahegn Gorfu; Kimberly M Cirelli; Mariane B Melo; Katrin Mayer-Barber; Devorah Crown; Beverly H Koller; Seth Masters; Alan Sher; Stephen H Leppla; Mahtab Moayeri; Jeroen P J Saeij; Michael E Grigg
Journal:  MBio       Date:  2014-02-18       Impact factor: 7.867

7.  Anthrax lethal factor cleaves mouse nlrp1b in both toxin-sensitive and toxin-resistant macrophages.

Authors:  Kristina A Hellmich; Jonathan L Levinsohn; Rasem Fattah; Zachary L Newman; Nolan Maier; Inka Sastalla; Shihui Liu; Stephen H Leppla; Mahtab Moayeri
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

8.  A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation.

Authors:  Laurence Braun; Marie-Pierre Brenier-Pinchart; Manickam Yogavel; Aurélie Curt-Varesano; Rose-Laurence Curt-Bertini; Tahir Hussain; Sylvie Kieffer-Jaquinod; Yohann Coute; Hervé Pelloux; Isabelle Tardieux; Amit Sharma; Hassan Belrhali; Alexandre Bougdour; Mohamed-Ali Hakimi
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

9.  Inflammasome sensor NLRP1 controls rat macrophage susceptibility to Toxoplasma gondii.

Authors:  Kimberly M Cirelli; Gezahegn Gorfu; Musa A Hassan; Morton Printz; Devorah Crown; Stephen H Leppla; Michael E Grigg; Jeroen P J Saeij; Mahtab Moayeri
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

10.  Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes.

Authors:  Elena Viganò; Catherine Emma Diamond; Roberto Spreafico; Akhila Balachander; Radoslaw M Sobota; Alessandra Mortellaro
Journal:  Nat Commun       Date:  2015-10-28       Impact factor: 14.919

View more
  29 in total

Review 1.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 2.  Inflammasomes: Their Role in Normal and Complicated Pregnancies.

Authors:  Nardhy Gomez-Lopez; Kenichiro Motomura; Derek Miller; Valeria Garcia-Flores; Jose Galaz; Roberto Romero
Journal:  J Immunol       Date:  2019-12-01       Impact factor: 5.422

3.  Frontline Science: Staphylococcus aureus promotes receptor-interacting protein kinase 3- and protease-dependent production of IL-1β in human neutrophils.

Authors:  Silvie Kremserova; William M Nauseef
Journal:  J Leukoc Biol       Date:  2018-12-13       Impact factor: 4.962

Review 4.  Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.

Authors:  Danbin Wu; Yefei Chen; Yingxin Sun; Qing Gao; Huhu Li; Zhengfei Yang; Yangxue Wang; Xijuan Jiang; Bin Yu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

5.  Evasion of Human Neutrophil-Mediated Host Defense during Toxoplasma gondii Infection.

Authors:  Tatiane S Lima; Lanny Gov; Melissa B Lodoen
Journal:  MBio       Date:  2018-02-13       Impact factor: 7.867

Review 6.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

Review 7.  Cellular Models and Assays to Study NLRP3 Inflammasome Biology.

Authors:  Giovanni Zito; Marco Buscetta; Maura Cimino; Paola Dino; Fabio Bucchieri; Chiara Cipollina
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 8.  Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii.

Authors:  Tatiane S Lima; Melissa B Lodoen
Journal:  Front Cell Infect Microbiol       Date:  2019-04-16       Impact factor: 5.293

9.  Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii.

Authors:  Alexandra Safronova; Alessandra Araujo; Ellie T Camanzo; Taylor J Moon; Michael R Elliott; Daniel P Beiting; Felix Yarovinsky
Journal:  Nat Immunol       Date:  2018-11-19       Impact factor: 25.606

10.  Inducible Nitric Oxide Synthase Is a Key Host Factor for Toxoplasma GRA15-Dependent Disruption of the Gamma Interferon-Induced Antiparasitic Human Response.

Authors:  Hironori Bando; Youngae Lee; Naoya Sakaguchi; Ariel Pradipta; Ji Su Ma; Shun Tanaka; Yihong Cai; Jianfa Liu; Jilong Shen; Yoshifumi Nishikawa; Miwa Sasai; Masahiro Yamamoto
Journal:  MBio       Date:  2018-10-09       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.